An updated COVID-19 vaccine is coming to Canada just in time for fall. On Tuesday, Health Canada announced it had approved ...

With the stock now more than cut in half from its 52-week high, the company recently laid out a plan for its business at its ...

Jim Cramer likes Pfizer and recommends buying more stock. Six Flags is struggling, but Cramer likes First Solar and Equity ...

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, ...

Moderna shares have dropped by over -41.67% since I last covered them over the summer. See why I continue to rate MRNA stock ...

Moderna’s cost-reduction plans, pipeline cuts and reined-in financial guidance, unveiled Thursday, triggered a wave of ...

Doses of Moderna's updated COVID-19 vaccine are expected to begin arriving in Canada "within days," a spokesperson for the Public Health Agency of Canada says, although availability will depend on the ...

The therapeutic vaccine, codenamed mRNA-4359, is intended to boost people's immunity to a variety of advanced solid tumor ...

Shares of Moderna tumbled early Thursday after the vaccine developer said it was cutting research and development spending ...

Shares of Moderna rose after the company said that the government of Canada authorized its updated Covid-19 vaccine, joining the U.S. in the approval. The stock was up 4.5% at $72.28 in Tuesday ...

Moderna pushed back its break-even goal by two years on Thursday as it delayed the timeline for developing several key ...

Moderna shares are down for the second day in a row after the company said it would slash its research and development costs.